Literature DB >> 7097399

Slow cirrhosis--or no cirrhosis? a lesion causing benign intrahepatic portal hypertension.

D A Levison, J G Kingham, A M Dawson, A G Stansfeld.   

Abstract

We report the histological findings in livers from a group of 60 patients with benign intrahepatic portal hypertension. The lesion is benign in comparison with true cirrhosis in the sense that most of the patients survive many years from the time of diagnosis. The histological changes, in our view, differ from those of any variant of cirrhosis and generally do not progress even after many years. The essential features are: (1) irregular capsular thickening; (2) thickening of some portal tracts with fine fibrous septa radiating out from some of them; and (3) distortion of lobular architecture with hyperplastic expansion of some areas and compression of others and irregularly distributed central veins. We suggest that this is the lesion responsible for at least some cases of so-called idiopathic non-cirrhotic portal hypertension.

Entities:  

Mesh:

Year:  1982        PMID: 7097399     DOI: 10.1002/path.1711370309

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  13 in total

1.  Implications of portal vein thrombosis after splenectomy for patients with idiopathic portal hypertension.

Authors:  Teijiro Hirashita; Masayuki Ohta; Seiichiro Kai; Takashi Masuda; Hidetoshi Eguchi; Yukio Iwashita; Tadashi Ogawa; Seigo Kitano
Journal:  Surg Today       Date:  2011-10-04       Impact factor: 2.549

2.  Expression of HLA-DR antigen on hepatic vascular endothelial cells in idiopathic portal hypertension.

Authors:  T Terada; Y Nakanuma; M Hoso; H Obata
Journal:  Clin Exp Immunol       Date:  1991-05       Impact factor: 4.330

3.  Contribution to the study of septal fibrosis of the liver.

Authors:  Z A Andrade
Journal:  Int J Exp Pathol       Date:  1991-10       Impact factor: 1.925

Review 4.  Porto-hepatic venous shunt via portal vein aneurysm with splenomegaly.

Authors:  F Hanatate; H Matsuoka; Y Mizuno; T Kitamura
Journal:  J Gastroenterol       Date:  1995-12       Impact factor: 7.527

Review 5.  Noncirrhotic portal hypertension.

Authors:  Harshal Rajekar; Rakesh K Vasishta; Yogesh K Chawla; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2011-11-09

6.  Non-cirrhotic portal hypertension with hypoxaemia.

Authors:  C Babbs; T W Warnes; N Y Haboubi
Journal:  Gut       Date:  1988-01       Impact factor: 23.059

7.  Elevated levels of circulating angiotensin converting enzyme in patients with hepatoportal sclerosis.

Authors:  Yavuz Beyazit; Mehmet Ibis; Tugrul Purnak; Turan Turhan; Murat Kekilli; Mevlut Kurt; Abdurrahim Sayilir; Ibrahim Koral Onal; Nesrin Turhan; Adnan Tas; Seyfettin Köklü; Ibrahim C Haznedaroglu
Journal:  Dig Dis Sci       Date:  2011-02-03       Impact factor: 3.199

8.  Use of serum vitamin B12 level as a marker to differentiate idiopathic noncirrhotic intrahepatic portal hypertension from cryptogenic cirrhosis.

Authors:  Ashish Goel; Banumathi Ramakrishna; Jayaprakash Muliyil; Kadiyala Madhu; K G Sajith; Uday Zachariah; Jeyamani Ramachandran; Shyamkumar N Keshava; R Selvakumar; George M Chandy; Elwyn Elias; C E Eapen
Journal:  Dig Dis Sci       Date:  2012-08-24       Impact factor: 3.199

9.  Analysis of inherited thrombophilic mutations and natural anticoagulant deficiency in patients with idiopathic portal hypertension.

Authors:  Kadim Bayan; Yekta Tüzün; Serif Yilmaz; Naime Canoruc; Mehmet Dursun
Journal:  J Thromb Thrombolysis       Date:  2008-08-07       Impact factor: 2.300

10.  Idiopathic non-cirrhotic intrahepatic portal hypertension in the West: a re-evaluation in 28 patients.

Authors:  S Hillaire; E Bonte; M-H Denninger; N Casadevall; J-F Cadranel; D Lebrec; D Valla; C Degott
Journal:  Gut       Date:  2002-08       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.